Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.48% | 5.34% | -12.77% | -13.01% | -17.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.48% | 5.34% | -12.77% | -13.01% | -17.46% |
| Cost of Revenue | -0.98% | 9.81% | -3.58% | -5.17% | -13.17% |
| Gross Profit | 9.16% | -7.63% | -30.56% | -32.87% | -28.48% |
| SG&A Expenses | -40.48% | -17.44% | -24.20% | -19.06% | -5.24% |
| Depreciation & Amortization | -15.55% | 2.92% | -52.66% | -25.14% | -10.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.32% | 3.57% | -12.95% | -10.62% | -9.91% |
| Operating Income | 84.14% | 14.04% | -6.48% | -14.34% | -71.93% |
| Income Before Tax | 68.05% | -3.62% | 90.00% | 10.46% | -6.57% |
| Income Tax Expenses | 32.52% | -23.04% | 40.41% | 427.27% | -459.09% |
| Earnings from Continuing Operations | 68.62% | -2.54% | 90.18% | 9.65% | -5.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.62% | -2.54% | 90.18% | 9.65% | -5.20% |
| EBIT | 84.14% | 14.04% | -6.48% | -14.34% | -71.93% |
| EBITDA | 175.66% | -438.90% | -21.04% | -785.09% | -922.77% |
| EPS Basic | 74.07% | 15.00% | 90.45% | 11.21% | -4.65% |
| Normalized Basic EPS | 75.00% | 14.58% | 75.68% | 9.68% | -20.55% |
| EPS Diluted | 75.86% | 8.75% | 84.71% | 35.37% | 0.68% |
| Normalized Diluted EPS | 75.00% | 14.58% | 75.68% | 9.68% | -20.55% |
| Average Basic Shares Outstanding | 22.00% | 20.90% | 3.61% | 1.52% | 0.45% |
| Average Diluted Shares Outstanding | 22.00% | 20.90% | 3.61% | 1.52% | 0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |